What it sells
Device to create an ostomy under local anaesthesia
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospitals and the surgeons/interventional teams who would perform the procedure; no commercial buyer yet because the device is investigational.
Trigger: what makes them buy now?
UnverifiedPatients too high-risk for open surgical ostomy creation; PercStoma is pitched as a minimally invasive alternative.
Workflow: what inputs become what output?
PercStoma (percutaneous ostomy): single needle access point, fixation device and stent deployed under fluoroscopy; claimed ~20-minute procedure, 3-day discharge, 2-minute reversal.
Distribution: how it reaches customers
Pre-commercial: recruiting clinical centers, investigators and strategic partners; device is investigational and not cleared by any regulator.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-08 | — | $5M | — | calcalistech.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.